Skip to main navigation

About us
Our Portfolio
DANYELZA®
Partnerships
Resources
Investors
Careers

About us
Our Portfolio
DANYELZA®
Partnerships
Resources
Investors
Careers

Event Details

First Quarter 2022 Financial and Operating Results

May 10, 2022 9:00 AM EDT

Listen to webcast

About us
Our Portfolio
DANYELZA®
Partnerships
Resources
Investors
Careers

Company

About Us
Leadership
Culture of Integrity
Community Guidelines
Careers
Contact

Science

Radiopharmaceuticals
Naxitamab
DANYELZA®
Partnerships
Scientific Resources

Support

ISS Grant Submission
Resources
Patients & Caregivers
Physicians

Investors

Overview
Stock Information
News & Presentations
Financial Information
Corporate Governance
Investor Resources

Accessibility
Cookie Policy
Privacy Statement
Terms of Use

Copyright © 2025 Y-mAbs Therapeutics, Inc. All rights reserved. CRP-000001 03/2024

Scroll to Top